Aptorum Group (NASDAQ:APM) Trading 2.5% Higher
Aptorum Group Ltd (NASDAQ:APM) traded up 2.5% during mid-day trading on Tuesday . The stock traded as high as $15.01 and last traded at $14.77, 4,357 shares were traded during mid-day trading. An increase of 76% from the average session volume of 2,469 shares. The stock had previously closed at $14.42.
Separately, ValuEngine cut Aptorum Group from a “buy” rating to a “hold” rating in a research note on Tuesday, December 31st.
The company has a debt-to-equity ratio of 0.01, a current ratio of 12.97 and a quick ratio of 12.91. The business has a 50-day moving average price of $14.64 and a 200 day moving average price of $16.78.
Aptorum Group Limited, a pharmaceutical company, develops and commercializes a range of therapeutic and diagnostic technologies to treat unmet medical needs. It focuses on developing various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas.
Featured Article: What causes a stock to be most active?
Receive News & Ratings for Aptorum Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptorum Group and related companies with MarketBeat.com's FREE daily email newsletter.